These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17176481)

  • 61. Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs.
    Jozaghi E; Jackson A
    Int J Health Policy Manag; 2015 Mar; 4(6):373-9. PubMed ID: 26029896
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation.
    Krüsi A; Small W; Wood E; Kerr T
    AIDS Care; 2009 May; 21(5):638-44. PubMed ID: 19444673
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IDU perspectives on the design and operation of North America's first medically supervised injection facility.
    Small W; Ainsworth L; Wood E; Kerr T
    Subst Use Misuse; 2011; 46(5):561-8. PubMed ID: 20874006
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Managing Addiction and Overdose Deaths: The Debate Over America's Safe Injection Spaces.
    Rasool F; Klein AA; Leheste JR
    Cureus; 2023 Dec; 15(12):e50406. PubMed ID: 38213341
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming.
    Lloyd-Smith E; Rachlis BS; Tobin D; Stone D; Li K; Small W; Wood E; Kerr T
    Harm Reduct J; 2010 Mar; 7():6. PubMed ID: 20302638
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users.
    Shannon K; Ishida T; Morgan R; Bear A; Oleson M; Kerr T; Tyndall MW
    Harm Reduct J; 2006 Jan; 3():1. PubMed ID: 16403229
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting.
    Miller CL; Strathdee SA; Spittal PM; Kerr T; Li K; Schechter MT; Wood E
    Harm Reduct J; 2006 Mar; 3():9. PubMed ID: 16524484
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada.
    Jozaghi E; Reid AA; Andresen MA
    Subst Abuse Treat Prev Policy; 2013 Jul; 8():25. PubMed ID: 23837814
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Amazing grace: Vancouver's supervised injection facility granted six-month lease on life.
    Small D
    Harm Reduct J; 2008 Jan; 5():3. PubMed ID: 18218101
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High prevalence of HIV infection among homeless and street-involved Aboriginal youth in a Canadian setting.
    Marshall BD; Kerr T; Livingstone C; Li K; Montaner JS; Wood E
    Harm Reduct J; 2008 Nov; 5():35. PubMed ID: 19019253
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Determinants of cutaneous injection-related infection care at a supervised injecting facility.
    Lloyd-Smith E; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Ann Epidemiol; 2009 Jun; 19(6):404-9. PubMed ID: 19364660
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Closed to reason: time for accountability for the International Narcotic Control Board.
    Small D; Drucker E
    Harm Reduct J; 2007 May; 4():13. PubMed ID: 17488506
    [TBL] [Abstract][Full Text] [Related]  

  • 73. DETERMINANTS OF CUTANEOUS INJECTION-RELATED INFECTIONS AMONG INJECTION DRUG USERS AT AN EMERGENCY DEPARTMENT.
    Lloyd-Smith E; Tyndall M; Zhang R; Grafstein E; Sheps S; Wood E; Montaner J; Kerr T
    Open Infect Dis J; 2012 Jan; 6():. PubMed ID: 24339842
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Canada's highest court unchains injection drug users; implications for harm reduction as standard of healthcare.
    Small D
    Harm Reduct J; 2012 Jul; 9():34. PubMed ID: 22817679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 'Because I've been extremely careful': HIV seroconversion, responsibility, citizenship and the neo-liberal drug-using subject.
    Krüsi A; McNeil R; Moore D; Small W
    Health Risk Soc; 2017; 19(1-2):58-73. PubMed ID: 28989321
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Portapotty Experiment: Neoliberal approaches to the intertwined epidemics of opioid-related overdose and HIV/HCV, and why we need cultural anthropologists in the South Bronx.
    Wolfson-Stofko B; Curtis R; Fuentes F; Manchess E; Del Rio-Cumba A; Bennett AS
    Dialect Anthropol; 2016 Dec; 40(4):395-410. PubMed ID: 27917016
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeted Outreach, Education, and Point-of-Care Testing for HIV and Hepatitis C: Strategies to Address HIV Infection in Marginalized Communities in Vancouver.
    Magel T; Conway B
    AIDS Patient Care STDS; 2020 Jul; 34(7):281-283. PubMed ID: 32639211
    [No Abstract]   [Full Text] [Related]  

  • 78. Acceptability of Overdose Prevention Sites in the Business Community in Baltimore, Maryland.
    Sherman SG; Rouhani S; White RH; Weicker N; Morris M; Schneider K; Park JN; Barry C
    J Urban Health; 2022 Aug; 99(4):723-732. PubMed ID: 35610474
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV and the criminalisation of drug use among people who inject drugs: a systematic review.
    DeBeck K; Cheng T; Montaner JS; Beyrer C; Elliott R; Sherman S; Wood E; Baral S
    Lancet HIV; 2017 Aug; 4(8):e357-e374. PubMed ID: 28515014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.